All Articles

As software firm Idox plc navigates a takeover, Sand Grove Capital's newly disclosed 5.26% stake signals a strategic play in a high-stakes deal.

Hedge fund Balyasny reveals a 1.25% stake in Empiric Student Property amid a major merger, signaling a calculated move in a red-hot market.

A French bank reveals a perfectly balanced long and short position in UK takeover target Spectris. Is it a complex hedge or a clever arbitrage play?

A complex derivative trade by Natixis reveals the high-stakes financial chess game being played as Brookfield’s £2.4B acquisition of Just Group nears.

A complex derivatives strategy by NATIXIS reveals how sophisticated investors are profiting from the high-stakes acquisition of JTC plc by Permira.

Amazon enters the digital signage market with a purpose-built device, partnering with Pickcel to democratize access and challenge established players.

Hedge fund Balyasny's 2.12% stake in Spectris isn't activism. It's a high-stakes merger arbitrage play on the impending £4.1B KKR acquisition.

Dynamic Funds' estimated distributions reveal a massive payout for its gold ETF, reflecting a banner year for mining stocks. Here's what it means for investors.

Canada's new Earthquake Early Warning system goes live in Ontario and Quebec, using a vast sensor network to protect citizens and critical infrastructure.

With major audits and a Q4 launch, Mutuum Finance shows promise. But can its security-first approach overcome concerns about its anonymous team?

A hedge fund's 0.99% derivative stake in a major UK property deal reveals how digital finance is reshaping M&A and corporate strategy.

A regulatory filing reveals how a financial giant is playing the Dowlais-AAM merger, offering a masterclass in high-stakes merger arbitrage strategy.

Sungrow's new iSolarDesign platform promises to slash solar project planning from days to minutes. Is this a tech leap or a strategic market grab?

Once overlooked, the HER3 protein is now a prime target for a new wave of immunotherapies, promising to overcome treatment resistance in major cancers.

After early setbacks, next-generation immunotherapies targeting NaPi2b offer renewed hope for patients with ovarian and lung cancer. Here's why.

Legend Biotech's award-winning investment in Ghent, Belgium, is more than a corporate win—it's scaling a cancer therapy revolution.

As AI transforms drug discovery, access to GPU power is critical. A new hybrid model from Hydaway Digital could unlock speed and efficiency for pharma R&D.

The Black Falcon Drone promises professional 4K features at a budget price, but a closer look reveals a stark gap between marketing and reality.

A new survey shows Quebecers oppose Bill 109's streaming rules over cost fears, pitting consumer choice against the government's cultural sovereignty goals.

Millimeter-precise digital twins and AI monitors are the new guardians of ancient art. Inside China's high-tech bid to preserve global cultural treasures.